For the twelve months ended Jul 31, 2026, Kewaunee Scientific Corporation reported $277.21M of revenue and $8.23M of net income.
KEQU revenueQ1 2027$66.32M
- Quarter YoY
- -6.7%
- QoQ
- -7.1%
- FY YoY
- +17.3%
- 5Y CAGR
- +13.8%
- 10Y CAGR
- +8.2%
KEQU revenue was $66.32M in fiscal Q1 2027 (ended Jul 31, 2026), down 6.7% from a year earlier and down 7.1% from the prior quarter. For the full fiscal 2026 it was $282.00M, up 17.3% from fiscal 2025. Compound annual growth was +13.8% over 5 years and +8.2% over 10 years. It rose in 7 of the last 10 fiscal years. Fiscal 2026 is the highest of the 15 fiscal years on file.
KEQU net incomeQ1 2027$1.71M
- Quarter YoY
- -44.8%
- QoQ
- -49.6%
- FY YoY
- -15.7%
- 10Y CAGR
- +9.7%
KEQU net income was $1.71M in fiscal Q1 2027 (ended Jul 31, 2026), down 44.8% from a year earlier and down 49.6% from the prior quarter. For the full fiscal 2026 it was $9.62M, down 15.7% from fiscal 2025. Compound annual growth was +9.7% over 10 years. It rose in 1 of the last 3 fiscal years.
KEQU EPSQ1 2027$0.58
- Quarter YoY
- -44.2%
- QoQ
- -48.7%
- FY YoY
- -15.9%
- 10Y CAGR
- +8.5%
KEQU diluted EPS was $0.58 in fiscal Q1 2027 (ended Jul 31, 2026), down 44.2% from a year earlier and down 48.7% from the prior quarter. For the full fiscal 2026 it was $3.22, down 15.9% from fiscal 2025. Compound annual growth was +8.5% over 10 years.
KEQU free cash flowQ1 2027$1.20M
- Quarter YoY
- -76.0%
- QoQ
- -73.4%
- FY YoY
- +16.5%
- 10Y CAGR
- +11.2%
KEQU free cash flow was $1.20M in fiscal Q1 2027 (ended Jul 31, 2026), down 76.0% from a year earlier and down 73.4% from the prior quarter. For the full fiscal 2026 it was $14.70M, up 16.5% from fiscal 2025. Compound annual growth was +11.2% over 10 years.
Source: XBRL data Kewaunee Scientific Corporation files with the SEC, latest filing dated Sep 11, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.